Exogenously administered testosterone maintains spermatogenesis quantitatively in adult rats actively immunized against gonadotropin-releasing hormone
- PMID: 1597140
- DOI: 10.1210/endo.130.6.1597140
Exogenously administered testosterone maintains spermatogenesis quantitatively in adult rats actively immunized against gonadotropin-releasing hormone
Abstract
The administration of testosterone via Silastic capsules has been shown previously to maintain advanced spermatid number quantitatively in intact rats in which LH but not FSH was suppressed, but not in hypophysectomized rats, indicating that pituitary factors in addition to LH are required for the quantitative maintenance of spermatogenesis in the rat. The objective of the present study was to examine whether testosterone is capable of maintaining quantitatively normal spermatogenesis in rats in which both LH and FSH are suppressed. Intact adult male rats were actively immunized against GnRH by intradermal injection of GnRH conjugated to human serum globulin; control rats received intradermal injections of saline and adjuvant. Four weeks after the primary immunization, GnRH-immunized rats received the first booster injection and, at the same time, received testosterone-filled polydimethylsiloxane (PDS) implants of 4, 8, 12, or 24 cm or empty implants. Booster injections were repeated every 2 weeks for 8 weeks. At that time, rats were killed, and serum levels of LH, FSH, and testosterone, testicular advanced spermatid number, and seminiferous tubule fluid testosterone concentrations were determined. Four weeks after the initial administration of GnRH immunogen, i.e. before the first booster injection, serum levels of testosterone, LH, and FSH and the number of advanced spermatids per testis were not different from those in controls. Eight weeks after the first booster injection, serum LH and FSH and advanced spermatids were undetectable in all GnRH-immunized rats. The administration of testosterone-filled PDS implants of 4 and 8 cm to GnRH-immunized rats for 8 weeks resulted in the maintenance of 105 +/- 6 and 161 +/- 5 x 10(6) advanced spermatid/testis, respectively, significantly less than the control value (237 +/- 19 x 10(6)). In GnRH-immunized rats that received testosterone-filled PDS implants of 12 or 24 cm, the advanced spermatid numbers per testis (228 +/- 4 and 229 +/- 8 x 10(6), respectively) were not significantly different from those in controls. These results indicate that testosterone is capable of maintaining spermatogenesis quantitatively in the adult rats testis, in the absence of both radioimmunoassayable LH and FSH.
Similar articles
-
Quantitative restoration of advanced spermatogenic cells in adult male rats made azoospermic by active immunization against luteinizing hormone or gonadotropin-releasing hormone.Endocrinology. 1989 Sep;125(3):1303-9. doi: 10.1210/endo-125-3-1303. Endocrinology. 1989. PMID: 2667955
-
Hypoprolactinemia does not prevent restoration of normal spermatogenesis in gonadotropin-suppressed, testosterone-replaced rats.J Androl. 1996 Jan-Feb;17(1):35-40. J Androl. 1996. PMID: 8833739
-
Testosterone effects on spermatogenesis in the gonadotropin-releasing hormone-immunized rat.Biol Reprod. 1994 Feb;50(2):271-80. doi: 10.1095/biolreprod50.2.271. Biol Reprod. 1994. PMID: 8142546
-
Role of FSH in male gonadal function.Ann Endocrinol (Paris). 1999 Jul;60(2):102-6. Ann Endocrinol (Paris). 1999. PMID: 10456180 Review.
-
Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man.Recent Prog Horm Res. 2002;57:149-79. doi: 10.1210/rp.57.1.149. Recent Prog Horm Res. 2002. PMID: 12017541 Review.
Cited by
-
Leydig Cell and Spermatogenesis.Adv Exp Med Biol. 2021;1288:111-129. doi: 10.1007/978-3-030-77779-1_6. Adv Exp Med Biol. 2021. PMID: 34453734
-
Simultaneous quantification of steroids in rat intratesticular fluid by HPLC-isotope dilution tandem mass spectrometry.J Androl. 2012 Jul-Aug;33(4):691-8. doi: 10.2164/jandrol.111.014977. Epub 2011 Oct 20. J Androl. 2012. PMID: 22016356 Free PMC article.
-
Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception.Endocrinology. 2009 Jan;150(1):385-95. doi: 10.1210/en.2008-0674. Epub 2008 Sep 4. Endocrinology. 2009. PMID: 18772237 Free PMC article.
-
Does Size Matter? Testicular Volume and Its Predictive Ability of Sperm Production in Rams.Animals (Basel). 2023 Oct 13;13(20):3204. doi: 10.3390/ani13203204. Animals (Basel). 2023. PMID: 37893928 Free PMC article.
-
Hormonal control of inhibin B in men.J Endocrinol Invest. 2006 Sep;29(8):706-13. doi: 10.1007/BF03344180. J Endocrinol Invest. 2006. PMID: 17033259
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous